John Renner | Profiles RNS

John A. Renner, MD

Professor

Boston University Chobanian & Avedisian School of Medicine

Psychiatry

MD, Case Western Reserve University
BA, Yale University

Websites

	Psychiatry Faculty
	Boston Medical Center Provider Profile
	ResearchGate

VA Boston Healthcare System

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Richardson C, Daniels K, Confer A, Saxon AJ, Gordon AJ, Liberto J, Albanese AP, Renner J, Edens E, Kennedy AJ. Internal Medicine Resident Addiction Training at the Veteran's Health Administration: A Qualitative Evaluation of Site Directors' Response to the 2022 ACGME Requirements. J Gen Intern Med. 2024 Jun; 39(8):1393-1399. PMID: 38302815; PMCID: PMC11169109; DOI: 10.1007/s11606-024-08639-4;

Funk MC, Nash S, Smith A, Barth K, Suzuki J, Rustad JK, Buonocore S, Khandai AC, Smith MA, Jin S, Drexler K, Renner JA. Treatment of Opioid Use Disorder in the General Hospital. Am J Psychiatry. 2023 Aug 01; 180(8):594-596. PMID: 37525604; PMCID: PMC10998288; DOI: 10.1176/appi.ajp.23180008;

Balasanova AA, Ritvo A, Renner JA. A call for increased addiction psychiatrist engagement in medical student education. Am J Addict. 2022 Sep; 31(5):403-405. PMID: 36071591; PMCID: PMC9542045; DOI: 10.1111/ajad.13298;

DeJong SM, Balasanova AA, Frank A, Ruble AE, Frew JR, Hoefer M, Rakocevic DB, Carey T, Renner JA, Schwartz AC. Addiction Teaching and Training in the General Psychiatry Setting. Acad Psychiatry. 2022 Jun; 46(3):381-388. PMID: 33709286

Renner JA. A Celebration of the 35th Anniversary of the American Academy of Addiction Psychiatry. Am J Addict. 2020 09; 29(5):362-364. PMID: 32902046

Rakocevic DB, DeJong SM, Saxon AJ, Renner JA, Schwartz AC. A Guide for Applying to Addiction Psychiatry Fellowship. Acad Psychiatry. 2020 Apr; 44(2):135-140. PMID: 31773502

Renner JA. Counteracting the Effect of Stigma on Education for Substance Use Disorders. Focus (Am Psychiatr Publ). 2019 Apr; 17(2):134-140. PMID: 31975969; PMCID: PMC6527011; DOI: 10.1176/appi.focus.20180039;

Montalvo C, Genovese N, Renner J. The problem of pain: Additive analgesic effect of tramadol and buprenorphine in a patient with opioid use disorder. Subst Abus. 2019; 40(2):136-139.View Related Profiles.

Montalvo, Cristina
Renner, John

PMID: 30835647

Renner JA. Practice in the face of a lethal epidemic. Am J Addict. 2018 Jan; 27(1):49-50. PMID: 29283488

Suzuki J, Ellison TV, Connery HS, Surber C, Renner JA. Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs. Acad Psychiatry. 2016 Jun; 40(3):498-502. PMID: 26017618

Showing 10 of 26 results. Show More

Daum AM, Berkowitz O, Renner JA. The evolution of chronic opioid therapy and recognizing addiction. JAAPA. 2015 May; 28(5):23-7.View Related Profiles.

Daum, Akiva
Renner, John
Berkowitz, Oren

PMID: 25853674; DOI: 10.1097/01.JAA.0000464268.60257.ad;

Suzuki J, Connery HS, Ellison TV, Renner JA. Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency. Am J Addict. 2014 Nov-Dec; 23(6):618-22. PMID: 25065457; PMCID: PMC4391742; DOI: 10.1111/j.1521-0391.2014.12143.x;

Schuman-Olivier Z, Connery H, Griffin ML, Wyatt SA, Wartenberg AA, Borodovsky J, Renner JA, Weiss RD. Clinician beliefs and attitudes about buprenorphine/naloxone diversion. Am J Addict. 2013 Nov-Dec; 22(6):574-80. PMID: 24131165; PMCID: PMC3801272; DOI: 10.1111/j.1521-0391.2013.12024.x;

Egan JE, Casadonte P, Gartenmann T, Martin J, McCance-Katz EF, Netherland J, Renner JA, Weiss L, Saxon AJ, Fiellin DA. The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment. J Gen Intern Med. 2010 Sep; 25(9):936-41. PMID: 20458550; PMCID: PMC2917666; DOI: 10.1007/s11606-010-1377-y;

Renner JA, Karam-Hage M, Levinson M, Craig T, Eld B. What do psychiatric residents think of addiction psychiatry as a career? Acad Psychiatry. 2009 Mar-Apr; 33(2):139-42. PMID: 19398628

Netherland J, Botsko M, Egan JE, Saxon AJ, Cunningham CO, Finkelstein R, Gourevitch MN, Renner JA, Sohler N, Sullivan LE, Weiss L, Fiellin DA. Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. 2009 Apr; 36(3):244-51. PMID: 18715741; PMCID: PMC2866292; DOI: 10.1016/j.jsat.2008.06.006;

Alford DP, Salsitz EA, Martin J, Renner JA. Commentary on letter entitled, "buprenorphine comes of age". J Addict Med. 2008 Mar; 2(1):51.View Related Profiles.

Alford, Daniel
Renner, John

PMID: 21768973; DOI: 10.1097/ADM.0b013e318159f989;

Alford DP, Salsitz EA, Martin J, Renner JA. Clinical case discussion: treating opioid dependence with buprenorphine. J Addict Med. 2007 Jun; 1(2):73-8.View Related Profiles.

Alford, Daniel
Renner, John

PMID: 21768938; DOI: 10.1097/ADM.0b013e3180691158;

Fiellin DA, Saxon A, Renner JA. Mental health after deployment to Iraq or Afghanistan. JAMA. 2006 Aug 2; 296(5):515; author reply 516. PMID: 16882956

Renner JA, Quinones J, Wilson A. Training psychiatrists to diagnose and treat substance abuse disorders. Curr Psychiatry Rep. 2005 Oct; 7(5):352-9. PMID: 16216153

O'Brien CP, Charney DS, Lewis L, Cornish JW, Post RM, Woody GE, Zubieta JK, Anthony JC, Blaine JD, Bowden CL, Calabrese JR, Carroll K, Kosten T, Rounsaville B, Childress AR, Oslin DW, Pettinati HM, Davis MA, Demartino R, Drake RE, Fleming MF, Fricks L, Glassman AH, Levin FR, Nunes EV, Johnson RL, Jordan C, Kessler RC, Laden SK, Regier DA, Renner JA, Ries RK, Sklar-Blake T, Weisner C. Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry. 2004 Nov 15; 56(10):703-13. PMID: 15556110

Renner JA. How to train residents to identify and treat dual diagnosis patients. Biol Psychiatry. 2004 Nov 15; 56(10):810-6. PMID: 15556127

Fudala PJ, Bridge TP, Herbert S, Williford WO, Chiang CN, Jones K, Collins J, Raisch D, Casadonte P, Goldsmith RJ, Ling W, Malkerneker U, McNicholas L, Renner J, Stine S, Tusel D. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003 Sep 4; 349(10):949-58. PMID: 12954743

Ling W, Charuvastra C, Collins JF, Batki S, Brown LS, Kintaudi P, Wesson DR, McNicholas L, Tusel DJ, Malkerneker U, Renner JA, Santos E, Casadonte P, Fye C, Stine S, Wang RI, Segal D. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction. 1998 Apr; 93(4):475-86. PMID: 9684386

O'Malley SS, Kosten TR, Renner JA. Dual diagnoses: substance abuse and personality disorders. New Dir Ment Health Serv. 1990; (47):115-37. PMID: 2277608

Renner JA. The changing patterns of psychiatric problems in Vietnam. Compr Psychiatry. 1973 Mar-Apr; 14(2):169-81. PMID: 4704550

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 25 publications over 20 distinct years, with a maximum of 3 publications in 2019